Le Lézard
Classified in: Health
Subject: SVY

The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024


NEW YORK, Dec. 10, 2019 /PRNewswire/ --

The diagnostic imaging services market is projected to grow at a CAGR of 5.1% during the forecast period.

Read the full report: https://www.reportlinker.com/p05830577/?utm_source=PRN

The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024. The major factors driving the growth of this market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening scope of clinical applications. On the other hand, factors such as the high cost of diagnostic imaging systems and the low reimbursement structure for outpatient imaging facilities are likely to restrain the growth of the diagnostic imaging services market to a certain extent in the coming years.

On the basis of modality, X-ray accounted for the largest share of the diagnostic imaging services market in 2018.
Diagnostic imaging services make use of different modalities for the diagnosis and detection of various medical conditions, such as neurology, dentistry, oncology, cardiovascular, and mammography.The key modalities used for providing these services include X-ray imaging, computed tomography, ultrasound, MRI, nuclear imaging, and mammography.

In 2018, the x-ray segment accounted for the largest share of the diagnostic imaging services market. The key factors driving the growth of this market include the rising geriatric population, lower cost of X-rays as compared to other imaging modalities, favorable returns on investments, and technological advancements in X-ray imaging systems.

The neurology segment accounted for the largest share of the MRI services market in 2018.
Based on application, the MRI services market is segmented into neurology, orthopedics, cardiovascular, pelvic & abdomen, and oncology.The neurology segment accounted for the largest share of the MRI services market in 2018.

The large share of this segment can be attributed to the aggressive R&D activities in neuroscience, favorable federal initiatives, and the growing incidence of brain injuries.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
The diagnostic imaging services market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the RoW.In 2018, North America commanded the largest share of the global diagnostic imaging service market.

However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period primarily due to the improving healthcare infrastructure, rising investments in diagnostic imaging, improving reimbursement scenario, and the growing insurance coverage in several APAC countries.

Breakdown of supply-side primary interviews:
? By Company Type: Tier 1 - 25%, Tier 2 - 30%, and Tier 3 - 45%
? By Designation: C-level - 26%, Director-level - 30%, and Others - 44%
? By Region: North America- 34%, Europe - 26%, APAC - 23%, and RoW - 17%

The major players in the market includes RadNet, Inc. (US), Sonic Healthcare (Australia), Dignity Health (US), Novant Health (US), Alliance Medical (UK), InHealth Group (UK), Medica Group (UK), Global Diagnostics (Australia), and Healthcare Imaging Services Pty Ltd. (Australia), among others.

Research Coverage
This research report categorizes the diagnostic imaging services market, by modality, application, end user, and region.The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth.

It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning individual growth trends, and it also forecasts the revenue of the market segments for four main regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis?industry trends, market shares of top players, and company profiles, which together form basic views.It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities.

The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Read the full report: https://www.reportlinker.com/p05830577/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 17:31
DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding...

at 17:30
Renowned cosmetic dermatology specialist Dr. Simon Ourian at Epione Beverly Hills introduces a groundbreaking solution to acne...

at 17:30
Workplace first aid kits should now contain naloxone rapidly reverse an opioid overdose, says the International Safety Equipment Association (ISEA). ISEA publishes the ANSI/ISEA Z308.1-2021 standard ? which provides minimum performance specifications...

at 17:16
According to a report published in the New York Post, approximately 1.2 million residents of the United States travel to Mexico each year for elective surgeries, seeking significant cost savings. These...

at 17:06
Spring is the perfect time to refresh your skin and revamp your daily skincare routine. As summer approaches, it's important to have a strong skin barrier and the products you need to protect it. As the founder of Nash Injections by Hannah, a...

at 17:05
Carisma Therapeutics Inc.  ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming presentation at the American Society of Clinical...



News published on and distributed by: